HeartSciences Inc. (HSCSW) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
Les analystes estiment Bénéfice par action (EPS) de $-20.00 et chiffre d'affaires de $0.00B pour le prochain exercice fiscal.
Historique du Bénéfice par action (EPS): 2024: réel $-18.74 vs est $-20.00 (dépassé +6.3%). 2025: réel $-9.34 vs est $-9.09 (manqué -2.8%). Précision des analystes: 95%.
Estimations du BPA — HSCSW
95%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$18.74
vs Est –$20.00
▲ 6.7% off
2025
Actual –$9.34
vs Est –$9.09
▼ 2.7% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Estimations du CA — HSCSW
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.000B
vs Est $0.000B
▼ 168.8% off
2025
Actual $0.000B
vs Est $0.000B
▼ 1,049.4% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Les autres consultent aussi
